Fapon Biopharma
June 16, 2025
Company Presentation

Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologies, we have built advanced drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. With a differentiated pipeline of leading drug candidates, we have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. Committed to innovation, we strive to deliver safer, more efficacious, affordable, and accessible biologics for everyone.

Company HQ City:
Dongguan
Company HQ State:
Guangdong
Company HQ Country:
China
Year Founded:
2015
Lead Product in Development:
FP008: anti-PD-1 x IL10M and other IL10M antibody fusion proteins
CEO
Vincent Huo
Development Phase of Lead Product
Phase I
What is your next catalyst (value inflection) update?
Sep 2025 first patient in
Primary Speaker